An open-label dose-escalation trial was performed to assess the safety and tolerability of high doses of coenzyme Q10 (CoQ10) in ALS. CoQ10, a cofactor in mitochondrial electron transfer, may improve the mitochondrial dysfunction in ALS. In this study, CoQ10 was safe and well tolerated in 31 subjects treated with doses as high as 3,000 mg/day for 8 months.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1212/01.wnl.0000187070.35365.d7 | DOI Listing |
Publication Analysis
Top Keywords
3000 mg/day
8
coenzyme q10
8
tolerance high-dose
4
high-dose 3000
4
mg/day coenzyme
4
q10 als
4
als open-label
4
open-label dose-escalation
4
dose-escalation trial
4
trial performed
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!